Stallion India Fluorochemicals Limited is engaged in selling Refrigerant and Industrial Gases and related products.Business Overview Stallion India Fluorochemicals Limited specializes in manufacturing and distributing refrigerants and specialty gases. With nearly two decades of expertise, the company blends Hydrofluorocarbons (HFCs) and Hydrofluoroolefins (HFOs) for applications across industries such as…
Stallion India Fluorochemicals Limited has informed the Exchange regarding a press release dated August 14, 2026, titled "Stallion India Fluorochemicals Reports Strong Q1 FY27 Performance; PAT Surges 79% YoY to ₹18.57 Crore".
Stallion India Fluorochemicals reported strong FY26 results: Revenue at ₹434.12 Cr (+14.40%), EBITDA ₹61.35 Cr (+23.34%), PAT ₹43.84 Cr (+35.61%). Growth drivers include a new R-32 manufacturing facility expected by Oct 2026 and expanding specialty gas infrastructure, targeting 30-35% revenue CAGR.
Stallion India Fluorochemicals appointed M/s. Himani R. Patel & Associates as its Internal Auditor. The Board approved this appointment following Audit Committee consideration, strengthening internal financial controls and oversight.
Stallion India Fluorochemicals granted 1.59 Cr Employee Stock Options (ESOPs) at Rs. 10 per option to staff. These options vest 100% in one year, aiming to boost employee alignment and retention.
Stallion India secured land for a new HFO plant in Rajasthan, boosting capacity and product range. This ₹200 Cr investment, supported by significant capital incentives, targets 30-35% revenue CAGR. It strengthens operational synergies and market position in fluorochemicals.
